HM Revenue and Customs Research

Hammersmith Medicines Research (HMR) is a leading contract research organization (CRO) based in London, specializing in Phase 1 and early Phase 2 clinical trials. Founded in 1993, the company provides a comprehensive suite of services including protocol design, clinical conduct, pharmacy services, data management, and medical writing. HMR operates a large, purpose-built facility with approximately 100 beds and an on-site laboratory, allowing for high-quality, regulated clinical research across various therapeutic areas. The company is well-regarded for its expertise in first-in-human studies and its ability to handle complex early-phase drug development programs for global pharmaceutical and biotechnology clients.